Transplantation and cellular therapy
Prophylactic Versus Preemptive Donor Lymphocyte Infusion in Refractory/Relapsed AML Post-Allogeneic Transplant: A Retrospective Comparative Study.
Ning Wu, Chen-Hua Yan, Jun Kong, Meng Lv, Xiao-Dong Mo, Yu-Qian Sun, Yi-Fei Cheng, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Yu Wang
Published: 202510.1016/j.jtct.2025.10.029
Abstract
Donor lymphocyte infusion (DLI) represents a standard approach for relapse prevention following allogeneic hematopoietic stem cell transplantation (allo-HSCT). This study compared outcomes between prophylactic DLI (Pro-DLI)-administered early post-tr…
Preview only. Read the full abstract at the source